Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „rates“
Suchtreffer
Begriffe & Kennungen
Benepali · 4.8 · There were no differences in rates of infection among patients treated with etanercept and those treated with
Eintrag öffnenBesponsa · 4.5 · 8 to alter the exposure of substrates of CYP enzymes, and N-acetyl-gamma-calicheamicin dimethylhydrazide is un
Eintrag öffnenBesremi · 4.5 · Therefore, care should be taken when ropeginterferon alfa-2b is co- substrates notably those having a narrow t
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on CYP2D6 substrates In healthy volunteers, the inhibitory potency of mirabegron towards
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on CYP2D6 substrates In healthy volunteers, the inhibitory potency of mirabegron towards
Eintrag öffnenBimzelx · 4.8 · Infection rates observed in HS Phase III clinical studies were similar to those observed in other 7 indication
Eintrag öffnenBimzelx · 4.8 · Infection rates observed in PsA and axSpA (nr-axSpA and AS) Phase III clinical studies were similar to those o
Eintrag öffnenBlutsenkung
Eintrag öffnenBorate
Eintrag öffnenBraftovi · 4.5 · CYP substrates Encorafenib is a strong inducer of CYP3A4. Concomitant use with agents that are substrates of C
Eintrag öffnenBraftovi · 4.5 · Transporter substrates In vivo, encorafenib is an inhibitor of OATP1B1, OATP1B3 and/or BCRP. Coadministration
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.5 · There was no effect of ticagrelor on cyclosporine blood levels. Effect of ticagrelor on other P-gp substrates
Eintrag öffnenBrilique · 4.5 · Ticagrelor is a mild CYP3A4 inhibitor. Co-administration of ticagrelor and CYP3A4 substrates with narrow thera
Eintrag öffnenBrilique · 4.5 · Ticagrelor is a mild CYP3A4 inhibitor. Co-administration of ticagrelor and CYP3A4 substrates with narrow thera
Eintrag öffnenBrilique · 4.5 · Ticagrelor is a mild CYP3A4 inhibitor. Co-administration of ticagrelor and CYP3A4 substrates with narrow thera
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnen